These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 1820293)
1. Studies of left ventricular dysfunction following myocardial infarction. Sharpe N Herz; 1991 Sep; 16 Spec No 1():272-7. PubMed ID: 1820293 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
3. The Survival and Ventricular Enlargement (SAVE) study: rationale and perspective. Pfeffer MA Herz; 1993 Dec; 18 Suppl 1():430-5. PubMed ID: 8125423 [TBL] [Abstract][Full Text] [Related]
4. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors. Sigurdsson A Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749 [TBL] [Abstract][Full Text] [Related]
5. Experiences with ACE inhibitors early after acute myocardial infarction. Rationale and design of the German Multicenter Study on the Effects of Captopril on Cardiopulmonary Exercise parameters post myocardial infarction (ECCE). Kleber FX; Reindl I; Wenzel M; Rodewyk P; Beil S; Kosloswki B; Doering W; Sabin GV; Hinzmann S; Winter UJ Herz; 1993 Dec; 18 Suppl 1():424-9. PubMed ID: 8125422 [TBL] [Abstract][Full Text] [Related]
6. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA; Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343 [TBL] [Abstract][Full Text] [Related]
7. [Indications for ACE inhibitors in the postinfarct period]. Ertl G; Gaudron P; Neubauer S; Hu K; Zdrojewski T; Horn M; Kochsiek K Z Kardiol; 1994; 83 Suppl 4():65-74. PubMed ID: 7856283 [TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarction. Melchior T; Gadsbøll N; Hildebrandt P; Køber L; Torp-Pedersen C Diabet Med; 1996 May; 13(5):450-6. PubMed ID: 8737027 [TBL] [Abstract][Full Text] [Related]
9. Reduced mortality and morbidity with the use of angiotensin-converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure. Yusuf S Herz; 1993 Dec; 18 Suppl 1():444-8. PubMed ID: 8125425 [TBL] [Abstract][Full Text] [Related]
10. [Current aspects of ACE inhibitor therapy from the cardiologic viewpoint]. Klein W; Eber B; Gasser R; Stoschitzky K; Schumacher M; Fruhwald FM; Zweiker R Wien Med Wochenschr; 1996; 146(11):221-4. PubMed ID: 8928518 [TBL] [Abstract][Full Text] [Related]
11. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)]. Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513 [TBL] [Abstract][Full Text] [Related]
12. Comparison of lisinopril and captopril in the treatment of left ventricular congestive heart failure--influence of duration of action on efficacy and safety. Giles TD Z Kardiol; 1991; 80 Suppl 2():35-9. PubMed ID: 1850941 [TBL] [Abstract][Full Text] [Related]
13. [Epidemiology and prognosis of myocardial infarct and chronic heart failure]. Ertl G; Gaudron P; Eilles C; Kochsiek K Herz; 1993 Dec; 18 Suppl 1():406-15. PubMed ID: 8125420 [TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin-converting enzyme inhibitor therapy on presence of late potentials detected using signal-averaged electrocardiography in patients with congestive heart failure. Vacek JL; Handlin LR; Beaufort CJ; Koenig CA Coron Artery Dis; 1993 Dec; 4(12):1109-13. PubMed ID: 8162243 [TBL] [Abstract][Full Text] [Related]
15. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study. Borghi C; Ambrosioni E; Am Heart J; 2007 Mar; 153(3):445.e7-14. PubMed ID: 17307427 [TBL] [Abstract][Full Text] [Related]
16. Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy. Møller JE; Dahlström U; Gøtzsche O; Lahiri A; Skagen K; Andersen GS; Egstrup K; Am Heart J; 2004 Mar; 147(3):494-501. PubMed ID: 14999200 [TBL] [Abstract][Full Text] [Related]
17. [Effect of ACE-inhibitors on left ventricular remodeling after acute anterior or posterior myocardial infarct. Cine- magnetic resonance tomography study]. Konermann M; Odenthal HJ; Altmann C; Laschewski F; Rawert B; Trappe HJ; Sanner BM Wien Med Wochenschr; 2000; 150(12):249-55. PubMed ID: 11008329 [TBL] [Abstract][Full Text] [Related]
18. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846 [TBL] [Abstract][Full Text] [Related]
19. [Captopril in the treatment of congestive heart failure in acute myocardial infarct]. Svejda J; Václavík P; Kopal V Vnitr Lek; 1993 Apr; 39(4):340-4. PubMed ID: 8351861 [TBL] [Abstract][Full Text] [Related]
20. Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure. Wada K; Fujimori A; Matsukawa U; Arai Y; Sudoh K; Yatsu T; Sasamata M; Miyata K Eur J Pharmacol; 2005 Jan; 507(1-3):145-51. PubMed ID: 15659304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]